Case File
efta-efta00911371DOJ Data Set 9OtherDS9 Document EFTA00911371
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00911371
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
To: Jeffrey Epstein <[email protected]>
Subject: RE:
Date: Mon, 23 May 2011 15:59:38 +0000
Importance Normal
Jeffrey,
This is extraordinarily generous.
and the CCFA will be over the moon.
FYI CCFA was instrumental in developing the infliximab TNF-alpha blocking medication
Thank you so much.
I trust this note finds you well. Call sometime to catch up.
All our best,
Woody,
Date: Mon, 23 May 2011 11:47:25 -0400
Subject: Re:
From: 'eevacationu maii.com
To:
CC:
•
I will donate 10 thousand. II
On Mon, May 23, 2011 at 11:26 AM, woodson merrell <
Hello. I hope this note finds you very well!
> wrote:
which is sponsored by the Crohn's and Colitis Foundation of
menca
, ew or
apter. am writing to see i you would consider supporting the team.
The goals of Take Steps are to raise awareness of Crohn's and Colitis, show solidarity with the appx. 1.4 million
Americans who have an Inflammatory Bowel Disease (IBD;
and to raise money
for research into treatments and cures. There have been a lot of exciting breakthroughs in understanding digestive
diseases, and promise of
ut funds are urgently needed! It is our fervent hope that a cure for
Crohn's will be establish
Helping others has been a great way fo
to feel better about her own struggles. For the past 3
years s
as onated her time weekly, including
If you feel moved to donate simply copy and paste the link
EFTA00911371
into your browser, which will take you to
Take Steps page where you can make a donation by clickinMIMI
!Md
e
.:Iso,
pass the word if you know someone else who might want to support the effort to find cures for
Thank you. With much love and gratitude,
***********************************************************
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected]. and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00911372
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
maii.comEmail
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.